Hot money net inflows hit $96.6M in November
ARLINGTON, Va. , Dec. 6, 2024 /PRNewswire/ -- The Board of Directors of The AES Corporation (NYSE: AES ) approved an increase of 2% in the Company's quarterly common stock dividend, from $0.1725 per share to $0.17595 per share, beginning in the first quarter of 2025. The Company's first quarter 2025 common stock dividend of $0.17595 per share is payable on February 14, 2025 to shareholders of record at the close of business on January 31 , 2025. Additional information regarding dividends paid by AES, including tax treatment, can be found on www.aes.com by selecting "Investors" then "Stock Information" and then "Dividend History." About AES The AES Corporation (NYSE: AES ) is a Fortune 500 global energy company accelerating the future of energy. Together with our many stakeholders, we're improving lives by delivering the greener, smarter energy solutions the world needs. Our diverse workforce is committed to continuous innovation and operational excellence, while partnering with our customers on their strategic energy transitions and continuing to meet their energy needs today. For more information, visit www.aes.com . Safe Harbor Disclosure This news release contains forward-looking statements within the meaning of the Securities Act of 1933 and of the Securities Exchange Act of 1934. Such forward-looking statements include, but are not limited to, those related to future earnings, growth and financial and operating performance. Forward-looking statements are not intended to be a guarantee of future results, but instead constitute AES' current expectations based on reasonable assumptions. Forecasted financial information is based on certain material assumptions. These assumptions include, but are not limited to, our expectations regarding accurate projections of future interest rates, commodity price and foreign currency pricing, continued normal levels of operating performance and electricity volume at our distribution companies and operational performance at our generation businesses consistent with historical levels, as well as the execution of PPAs, conversion of our backlog and growth investments at normalized investment levels, and rates of return consistent with prior experience. Actual results could differ materially from those projected in our forward-looking statements due to risks, uncertainties and other factors. Important factors that could affect actual results are discussed in AES' filings with the Securities and Exchange Commission (the "SEC"), including, but not limited to, the risks discussed under Item 1A: "Risk Factors" and Item 7: "Management's Discussion & Analysis" in AES' 2023 Annual Report on Form 10-K and in subsequent reports filed with the SEC. Readers are encouraged to read AES' filings to learn more about the risk factors associated with AES' business. AES undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except where required by law. Any Stockholder who desires a copy of the Company's 2023 Annual Report on Form 10-K filed February 26, 2024 with the SEC may obtain a copy (excluding the exhibits thereto) without charge by addressing a request to the Office of the Corporate Secretary, The AES Corporation, 4300 Wilson Boulevard, Arlington, Virginia 22203. Exhibits also may be requested, but a charge equal to the reproduction cost thereof will be made. A copy of the Annual Report on Form 10-K may be obtained by visiting the Company's website at www.aes.com . Website Disclosure AES uses its website, including its quarterly updates, as channels of distribution of Company information. The information AES posts through these channels may be deemed material. Accordingly, investors should monitor our website, in addition to following AES' press releases, quarterly SEC filings and public conference calls and webcasts. In addition, you may automatically receive e-mail alerts and other information about AES when you enroll your e-mail address by visiting the " Subscribe to Alerts " page of AES' Investors website. The contents of AES' website, including its quarterly updates, are not, however, incorporated by reference into this release. Investor Contact: Susan Harcourt 703-682-1204, [email protected] Media Contact: Amy Ackerman 703-682-6399, [email protected] SOURCE The AES CorporationHemodynamic Monitoring Market: Trends, Size, Share, Growth, and Demand by 2031 11-27-2024 08:11 PM CET | Advertising, Media Consulting, Marketing Research Press release from: Data Bridge Market Research (DBMR) Hemodynamic Monitoring Market The healthcare industry is undergoing a profound transformation, driven by advancements in technology and a growing emphasis on patient-centric care. One sector experiencing significant innovation is the hemodynamic monitoring market. Hemodynamic monitoring, essential for assessing cardiovascular health and guiding therapeutic interventions, has become a cornerstone of critical care, surgery, and cardiology. By 2031, this market is projected to expand at an impressive pace, reflecting a combination of technological advancements, growing patient populations, and evolving medical needs. Access Full 350 Pages PDF Report @ https://www.databridgemarketresearch.com/reports/global-hemodynamic-monitoring-market Hemodynamic monitoring refers to the measurement of blood flow and pressure within the cardiovascular system. It provides critical data about the heart's efficiency, vascular resistance, and overall circulatory health. The data obtained aids clinicians in diagnosing conditions such as sepsis, heart failure, and shock, and in guiding treatment strategies during high-risk surgeries or intensive care scenarios. The monitoring techniques are categorized into invasive, minimally invasive, and non-invasive approaches. Invasive methods, such as pulmonary artery catheterization, are highly accurate but involve risks. Non-invasive methods, leveraging technologies like Doppler ultrasound, are gaining traction for their safety and ease of use. As healthcare systems worldwide prioritize precision medicine and advanced patient management, the demand for hemodynamic monitoring devices continues to surge. Trends Shaping the Hemodynamic Monitoring Market Several key trends are propelling the growth and innovation within the hemodynamic monitoring market: Technological Advancements Manufacturers are leveraging AI, IoT, and big data analytics to develop smart and connected hemodynamic monitoring systems. These innovations enable real-time data tracking, remote monitoring, and predictive analytics, improving patient outcomes. Portable and wearable hemodynamic monitors are also gaining popularity due to their convenience in outpatient settings. Shift Toward Non-Invasive Monitoring Non-invasive methods are witnessing higher adoption rates owing to their safety profile and ease of application. Devices utilizing technologies such as bioimpedance and photoplethysmography (PPG) are becoming more accurate and affordable, driving their use in diverse healthcare environments. Rising Prevalence of Chronic Diseases Cardiovascular diseases, diabetes, and hypertension are on the rise globally, increasing the need for continuous and effective monitoring solutions. Aging populations in developed countries further amplify this demand, as elderly patients often require comprehensive cardiovascular assessments. Integration of Telemedicine The integration of hemodynamic monitoring with telemedicine platforms is revolutionizing patient care. Remote monitoring devices enable clinicians to track patients' cardiovascular health from afar, ensuring timely interventions and reducing hospital admissions. Growing Focus on Personalized Healthcare Personalized medicine emphasizes treatments tailored to individual patients. Hemodynamic monitoring plays a crucial role in this approach by providing real-time, patient-specific data that guides customized therapeutic decisions. Market Size and Share Analysis The global hemodynamic monitoring market is expected to gain market growth in the forecast period of 2024 to 2031. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.2% in the forecast period of 2024 to 2031 and is expected to reach USD 3,839,125.07 thousand by 2031 from USD 2,214,354.71 thousand in 2023. Regional Insights North America dominates the market, accounting for a significant share due to advanced healthcare infrastructure, high adoption rates of innovative technologies, and a growing elderly population. Europe holds the second-largest share, driven by government healthcare initiatives and rising prevalence of cardiovascular diseases. Asia-Pacific is emerging as the fastest-growing region, fueled by increasing healthcare expenditure, a rising middle-class population, and a growing focus on improving healthcare services in countries like China and India. Latin America, the Middle East, and Africa are also witnessing gradual growth as awareness and access to advanced medical technologies improve. Segment Insights By Product Type: The market is segmented into monitoring systems and disposables. Monitoring systems dominate the segment due to their recurring demand in critical care settings. By Modality: Invasive, minimally invasive, and non-invasive are the primary modalities. Non-invasive techniques are rapidly gaining ground due to technological improvements and patient safety considerations. By End-User: Hospitals remain the largest end-users, but outpatient settings and home care are growing rapidly, driven by the demand for portable monitoring devices. Growth Drivers The growth of the hemodynamic monitoring market can be attributed to several factors: Increased Surgical Procedures With a rise in complex surgeries such as organ transplants and cardiovascular interventions, the need for advanced monitoring devices during perioperative and postoperative phases has grown significantly. Focus on Early Diagnosis Healthcare providers are placing a stronger emphasis on early detection of cardiovascular conditions, which requires sophisticated monitoring systems. Rising Healthcare Expenditure Increased healthcare spending in developing countries is enabling the procurement of advanced monitoring systems, bridging the gap between technology-rich and resource-constrained regions. Regulatory Support Governments worldwide are incentivizing the adoption of advanced healthcare technologies through subsidies, grants, and favorable policies, further boosting the market. Challenges in the Market Despite promising growth, the hemodynamic monitoring market faces challenges such as: High Costs: Advanced monitoring systems can be expensive, limiting their adoption in low-income regions. Skill Gap: Operating complex monitoring devices requires trained professionals, which can be a constraint in underdeveloped areas. Regulatory Hurdles: Stringent approval processes for medical devices can delay product launches and innovation. Future Demand and Outlook to 2031 The demand for hemodynamic monitoring systems is set to rise significantly by 2031, driven by evolving healthcare needs and technological advancements. Portable and wearable devices are expected to dominate, reflecting a shift toward patient-friendly solutions. Additionally, the integration of artificial intelligence will enhance predictive capabilities, allowing for earlier interventions and better outcomes. Emerging markets in Asia-Pacific and Latin America are anticipated to contribute significantly to growth, as governments invest in healthcare infrastructure and the adoption of modern technologies becomes widespread. Browse Trending Reports: https://aimarketresearch2024.blogspot.com/2024/11/hemiballismus-treatment-market-size_27.html https://aimarketresearch2024.blogspot.com/2024/11/hemodynamic-monitoring-market-size.html https://aimarketresearch2024.blogspot.com/2024/11/high-performance-lubricant-market-size.html https://aimarketresearch2024.blogspot.com/2024/11/human-milk-oligosaccharides-in-infant.html In conclusion, the hemodynamic monitoring market is poised for robust growth, supported by a confluence of technological innovation, rising patient awareness, and the increasing prevalence of cardiovascular and chronic diseases. By 2031, this market will not only transform critical care practices but also pave the way for a new era of precision medicine. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Contact Us: Data Bridge Market Research US: +1 614 591 3140 UK: +44 845 154 9652 APAC : +653 1251 975 Email: corporatesales@databridgemarketresearch.com" This release was published on openPR.
Women will for the first time make up a majority of state legislators in Colorado and New Mexico next year, but at least 13 states saw losses in female representation after the November election, according to a count released Thursday by the Rutgers Center for American Women and Politics. While women will fill a record number of state legislative seats in 2025, the overall uptick will be slight, filling about a third of legislative seats. Races in some states are still being called. “We certainly would like to see a faster rate of change and more significant increases in each election cycle to get us to a place where parity in state legislatures is less novel and more normal,” said Kelly Dittmar, director of research at the CAWP, which is a unit of the Eagleton Institute of Politics at Rutgers University. As of Wednesday, at least 2,450 women will serve in state legislatures, representing 33.2% of the seats nationwide. The previous record was set in 2024 with 2,431 women, according to the CAWP. The number of Republican women, at least 851, will break the previous record of 815 state lawmakers set in 2024. “But still, Republican women are very underrepresented compared to Democratic women,” Debbie Walsh, director of the CAWP, said. By the most recent count, 19 states will have increased the number of women in their state legislatures, according to the CAWP. The most notable increases were in New Mexico and Colorado where women will for the first time make up a majority of lawmakers. In New Mexico, voters sent an 11 additional women to the chambers. Colorado had previously attained gender parity in 2023 and is set to tip over to a slight female majority in the upcoming year. The states follow Nevada , which was the first in the country to see a female majority in the legislature following elections in 2018. Next year, women will make up almost 62% of state lawmakers in Nevada, far exceeding parity. Women in California’s Senate will make up the chamber’s majority for the first time in 2025 as well. Women also made notable gains in South Dakota, increasing its total number by at least nine. At least thirteen states emerged from the election with fewer female lawmakers than before, with the most significant loss occurring in South Carolina. Earlier this year, the only three Republican women in the South Carolina Senate lost their primaries after they stopped a total abortion ban from passing. Next year, only two women, who are Democrats, will be in the 46-member Senate. No other state in the country will have fewer women in its upper chamber, according to the CAWP. Women make up 55% of the state’s registered voters. Half the members in the GOP dominated state were elected in 2012 or before, so it will likely be the 2040s before any Republican woman elected in the future can rise to leadership or a committee chairmanship in the chamber, which doles out leadership positions based on seniority. A net loss of five women in the legislature means they will make up only about 13% of South Carolina's lawmakers, making the state the second lowest in the country for female representation. Only West Virginia has a smaller proportion of women in the legislature. West Virginia stands to lose one more women from its legislative ranks, furthering its representation problem in the legislature where women will make up just 11% of lawmakers. Many women, lawmakers and experts say that women's voices are needed in discussions on policy especially at a time when state government is at its most powerful in decades. Walsh, director of the CAWP, said the new changes expected from the Trump administration will turn even more policy and regulation to the states. The experiences and perspectives women offer will be increasingly needed, she said, especially on topics related to reproductive rights, healthcare, education and childcare . “The states may have to pick up where the federal government may, in fact, be walking away,” Walsh said. “And so who serves in those institutions is more important now than ever.” This version corrects the approximate total of women in state legislatures nationside to be about a third. The Associated Press’ women in the workforce and state government coverage receives financial support from Pivotal Ventures. AP is solely responsible for all content. Find AP’s standards for working with philanthropies, a list of supporters and funded coverage areas at AP.org .None
None
EXCLUSIVE : Tony and Pulitzer Prize winner David Auburn ( Proof ) has been tapped to write a new draft of Another Round , the English-language remake of Thomas Vinterberg’s Oscar-winning Danish drama from 2020, which has Chris Rock on board to direct. Rock joined the project in January, as we were first to report. At the time, he had a draft in hand from Stuart Blumberg but was looking for another writer with which to partner. We’re told Auburn landed the job after a long search, beating out maybe 200 scribes in the process. Leonardo DiCaprio’s Appian Way Productions secured the remake rights to Another Round shortly after the film landed the Best International Feature prize at the Academy Awards. We’re told that the project is picking up steam now that Auburn is involved, though Rock did just sign on to direct and star in Misty Green , a Hollywood drama for which he wrote the script, in November. So how soon we might hear about further developments on Another Round is not yet clear. Introduced to buyers at the American Film Market, Misty Green is just the latest film Rock has eyed to direct, on the heels of a Universal-based adaptation of King: A Life , the Jonathan Eig book about Martin Luther King Jr. Pic was described by our sources as a contemporary tale of Hollywood excess and inequality. Another Round , meanwhile, watches as four high school teachers consume alcohol on a daily basis to see how it affects their social and professional lives. Vinterberg directed the darkly comedic drama from his script written with Tobias Lindholm, with Mads Mikkelsen in the lead. In addition to the Oscar, the film was recognized with a BAFTA and numerous European Film Awards, including Best Film, Best Director, Best Actor, and Best Screenwriter. Brad Weston will produce the remake for Makeready, alongside Jennifer Davisson and DiCaprio for Appian Way. Exec producers include Vinterberg, Sisse Graum Jorgensen, and Kasper Dissing. Mike Hampton is overseeing for Appian Way. Fifth Season is the studio on the project. Auburn is well known for his play Proof , which won the 2001 Pulitzer Prize for Drama and the Tony Award for Best Play, and was adapted into a 2005 drama, starring Gwyneth Paltrow, Anthony Hopkins, Jake Gyllenhaal, and Hope Davis, by Miramax. Taking on a number of other high-level studio jobs over the last few years, Auburn also wrote The Lake House , the romance starring Sandra Bullock and Keanu Reeves, for Warner Bros. Auburn is repped by Verve, manager Rich Freeman of Code Entertainment, and attorney David Matlof of Hirsch Wallerstein Hayum.